Ionis Pharmaceuticals Inc. buy BMO Capital Markets
Start price
03.09.25
/
50%
€51.62
Target price
03.09.26
€60.18
Performance (%)
23.48%
Price
13.04.26
€63.74
Summary
This prediction is currently active. The prediction currently has a performance of 23.48%. This prediction currently runs until 03.09.26. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ionis Pharmaceuticals Inc. | -1.696% | -1.696% |
| iShares Core DAX® | 4,24 % | 2,86 % |
| iShares Nasdaq 100 | 4,89 % | 2,81 % |
| iShares Nikkei 225® | 9,40 % | 7,83 % |
| iShares S&P 500 | 3,53 % | 1,95 % |
Comments by BMO_Capital_Markets for this prediction
In the thread Ionis Pharmaceuticals Inc. diskutieren
Ionis Pharmaceuticals (NASDAQ:IONS) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating. They now have a $70.00 price target on the stock.
Ratings data for IONS provided by MarketBeat